Toggle Mobile Navigation

Prioritizing Clinical Quality: J&J, Biogen and Alexion Drive Top-Down Approaches

Learn how leading pharma, biotech, and device companies are driving a quality culture at the 9th Clinical Quality Oversight Forum, taking place October 10-12 in Philadelphia. Join more than 175 clinical quality, compliance, and operations professionals to strategize on how to effectively oversee both vendors and sites, and learn best practices for achieving ICH E6 R2 compliance.

Click here to register and use Priority Code ExL-Blog

 

Featured Session

SENIOR LEADERS PANEL: PRIORITIZING QUALITY

Driving Quality From the Top-Down to Build a Successful Quality Culture

Greg Dombal

Moderator
Greg DombalChief Operating OfficerHALLORAN CONSULTING GROUP

Panelists

Kira Drummond

Kira DrummondChief Operating OfficerHALLORAN CONSULTING GROUP

Federico A. Feldstein

Federico A. Feldstein, J.D.Vice President, Head of R&D Quality and ComplianceJOHNSON & JOHNSON

Melissa Mudrick

Melissa MudrickVice President and Global Head, R&D Quality and ComplianceBIOGEN

  • Defining the purpose and goal of a quality culture
  • Identifying the critical success factors
  • Examining best practices for initiating the shift from a reactive issue-based focus to a proactive risk-based focus
  • Determining the organization’s risk tolerance level
  • Driving quality as a priority among all stakeholders

 

Interactive Workshops on October 10

Dive deeper into these topics with extended, interactive sessions:

  • Understanding CRO Oversight Post-ICH E6 R2
  • Establishing Quality Tolerance Limits
  • Mitigating Risk at the Site Level

Discounted rates expire this Friday, August 17 for the 9th Clinical Quality Oversight Forum on October 10-12 in Philadelphia. Click here to register and use Priority Code ExL-Blog.

Sponsors and Exhibitors

Sponsors

Our exhibit hall is almost SOLD OUT, so contact Arthur Butler right away if you are interested in exploring the available sponsorship and exhibition options. Arthur can be reached at 917-932-0420 or abutler@exlevents.com.

For all other questions and comments, please contact Kristen Hunter at 212-400-6241 or khunter@exlevents.com.

LinkedIn Logo

 Be Part of the Conversation!

Join over 4K of your peers in our Proactive GCP Compliance LinkedIn discussion group. Click here and request to join.

posted in ExL Events News

live chat software